261 filings
Page 9 of 14
8-K
7n6hh2lrri1mrj
5 Mar 18
Fate Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Operational Progress
12:00am
8-K
0jpgr5wg
17 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
sq63lbffwx
14 Dec 17
Fate Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
424B5
pnvqf6trodkcsy a42y
13 Dec 17
Prospectus supplement for primary offering
12:00am
424B5
qbfht1
12 Dec 17
Prospectus supplement for primary offering
12:00am
8-K
w3za56u4
12 Dec 17
Other Events
12:00am
8-K
41d77cuzknv
1 Nov 17
Fate Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
EFFECT
djldmrwn1v 0n
25 Aug 17
Notice of effectiveness
12:00am
CORRESP
epgkwan1tl18 1zo6mh
23 Aug 17
Correspondence with SEC
12:00am
UPLOAD
f4ly3qqmd5 xh6pvtq
22 Aug 17
Letter from SEC
12:00am
S-8
i4gj308jg uumhn1crm
15 Aug 17
Registration of securities for employees
12:00am
8-K
g8asbua9 zf14cnwec
14 Aug 17
Fate Therapeutics Reports Second Quarter 2017 Financial Results
12:00am
8-K
52uc qlguh7bch
14 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
1wlrpf4gy4azqonn
15 May 17
Fate Therapeutics Reports First Quarter 2017 Financial Results
12:00am
8-K
6wj2uicr
8 May 17
Submission of Matters to a Vote of Security Holders
12:00am